IP Library Granted Patent US 12704507
Granted Patent B2
US 12704507 · App. 17/940,254 · Granted Aug 11, 2026

Multifunctional magnetic-optical nanoparticles

Inventors: Young Keun Kim (Seoul, KR); Hong En Fu (Seoul, KR); Thomas Myeongseok Koo (Seoul, KR)
Assignee: Korea University Research and Business Foundation
G01N33/54346C09K11/02C09K11/565C09K11/883G01N21/6428G01N33/54326G01N2021/6439
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12704507
App. No.
17/940,254
Granted
Aug 11, 2026
Kind
B2
Abstract

The method of preparing multifunctional magnetic-optical nanoparticles, includes: preparing magnetic nanoparticle clusters by mixing an oily phase containing magnetic nanoparticles and an aqueous phase containing a cationic surfactant; coating the magnetic nanoparticle clusters with a water-soluble polymer; and preparing multifunctional magnetic-optical nanoparticles by mixing a cluster solution containing magnetic nanoparticle clusters coated with the water-soluble polymer and a quantum dot solution containing quantum dot nanoparticles, wherein the solvent of the cluster solution has a higher polarity index than the solvent of the quantum dot solution.

Claims (32)

1 . A method of preparing multifunctional magnetic-optical nanoparticles, including:

preparing magnetic nanoparticle clusters by mixing an oily phase containing magnetic nanoparticles and an aqueous phase containing a cationic surfactant;

coating the magnetic nanoparticle clusters with a water-soluble polymer; and

preparing multifunctional magnetic-optical nanoparticles by mixing a cluster solution containing magnetic nanoparticle clusters coated with the water-soluble polymer and a quantum dot solution containing quantum dot nanoparticles,

wherein the solvent of the cluster solution has a higher polarity index than the solvent of the quantum dot solution, and

wherein the cationic surfactant includes one or more selected from the group consisting of dodecyltrimethylammonium bromide (DTAB), cetyltrimethylammonium bromide (CTAB) and tetradecyltrimethylammonium bromide (TTAB).

2 . The method of claim 1 , wherein the magnetic nanoparticles are metal oxide nanoparticles including one or more selected from the group consisting of FeO, Fe 2 O 3 , Fe 3 O 4 , CoFe 2 O 4 , NiFe 2 O 4 , MnFe 2 O 4 , TiO 2 , ZrO 2 , CeO 2 , Al 2 O 3 and MgO.

3 . The method of claim 1 , wherein the solvent of the oily phase is chloroform, hexane, octane, toluene, or a mixture thereof.

4 . The method of claim 1 , wherein the solvent of the aqueous phase is water, alcohol, acetone, dimethyl sulfoxide (DMSO), acetic acid, or a mixture thereof.

5 . The method of claim 1 , wherein the average particle diameter of the magnetic nanoparticle clusters is 50 to 500 nm.

6 . The method of claim 1 , wherein the water-soluble polymer includes one or more selected from the group consisting of polyvinylpyrrolidone and polyacrylic acid.

7 . The method of claim 1 , wherein the quantum dot nanoparticles include one or more selected from the group consisting of cadmium selenide-cadmium sulfide (CdSe—CdS), cadmium selenide (CdSe), cadmium sulfide (CdS), zinc oxide (ZnO), zinc selenide (ZnSe), zinc sulfide (ZnS), manganese-doped zinc sulfide (Mn-doped ZnS), indium phosphide (InP), and cesium lead halide (CsPbBr 3 , CsPbI 3 ) quantum dots.

8 . The method of claim 7 , wherein the quantum dot nanoparticles are cadmium selenide-cadmium sulfide (CdSe—CdS),

the cadmium selenide-cadmium sulfide is prepared by adding a cadmium ion precursor, a sulfur ion precursor and a stabilizing agent to a solution containing cadmium selenide quantum dots and reacting the same.

9 . The method of claim 8 , wherein the stabilizing agent is one or more selected from the group consisting of oleylamine (OAm), oleic acid (OA), dibenzylamine and octadecylamine.

10 . The method of claim 1 , wherein the solvent of the cluster solution is ethanol, methanol, acetone, dimethyl sulfoxide, or a mixture thereof, and

the solvent of the quantum dot nanoparticle solution is chloroform, isopropanol, or a mixture thereof.

11 . The method of claim 1 , wherein the difference in polarity between a solvent of the cluster solution and a solvent of the quantum dot solution is 0.5 to 2.

12 . The method of claim 1 , wherein, in the step of preparing the multifunctional magnetic-optical nanoparticles, the quantum dot nanoparticles penetrate into the inside of the magnetic nanoparticle cluster to form multifunctional magnetic-optical nanoparticles.

13 . The method of claim 1 , wherein the size of the prepared multifunctional magnetic-optical nanoparticles is 100 to 800 nm.

14 . The method of claim 1 , further including coating the prepared multifunctional magnetic-optical nanoparticles with a biocompatible polymer.

15 . The method of claim 14 , wherein the biocompatible polymer include one or more functional groups selected from the group consisting of an amine group (—NH 2 ), a thiol group (—SH), a carboxyl group (—COOH) and a hydroxyl group (—OH) at an end of the biocompatible polymer.

16 . The method of claim 14 , wherein the biocompatible polymer includes one or more selected from the group consisting of polyacrylic acid (PAA), polyethylene glycol (PEG), polylactic acid (PLA) and polyglycolic acid (PGA).

17 . A multifunctional magnetic-optical nanoparticle prepared by the preparing method of claim 1 , the nanoparticle including:

a core including quantum dot nanoparticles; and

a shell including magnetic nanoparticles and the quantum dot nanoparticles,

the content of the quantum dot nanoparticles in the shell is 40% or less based on the total weight of the shell.

18 . A composition for imaging including the multifunctional magnetic-optical nanoparticles of claim 17 , a kit for detecting an analyte, or a molecular diagnostic chip.

19 . A method of imaging or detecting an analyte, including:

functionalizing the surface of the multifunctional magnetic-optical nanoparticles of claim 17 with a biomolecule capable of binding to an analyte to be detected;

exposing the functionalized multifunctional magnetic-optical nanoparticles to a sample containing one or more analytes; and

identifying the analyte bound to the multifunctional magnetic-optical nanoparticles using photoluminescence spectroscopy.